Evidence map›Paper›PMID 23742907›Full record

ArticleNucleic acids research2013

MCPath: Monte Carlo path generation approach to predict likely allosteric pathways and functional residues.

Cihan Kaya, Andac Armutlulu, Solen Ekesan, Turkan Haliloglu

Abstract read
In one paragraph

Article in Nucleic acids research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Allosteric Modulators of Dopamine DMolecules (Basel, Switzerland) · 2022
    Review
  4. Article
  5. Normal Mode Analysis of KRas4B Reveals Partner Specific Dynamics.The journal of physical chemistry. B · 2021
    Article
  6. Article
  7. Review
  8. Integrated Computational Approaches and Tools forAllosteric Drug Discovery.International journal of molecular sciences · 2020
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Seeking allosteric networks in PDZ domains.Protein engineering, design & selection : PEDS · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Cihan KayaDepartment of Chemical Engineering and Polymer Research Center, Bogazici University, Bebek, 34342, Istanbul, Turkey.
Andac Armutlulu
Solen Ekesan
Turkan Haliloglu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allosteric mechanism of proteins is essential in biomolecular signaling. An important aspect underlying this mechanism is the communication pathways connecting functional residues. Here, a Monte Carlo (MC) path generation approach is proposed and implemented to define likely allosteric pathways through generating an ensemble of maximum probability paths. The protein structure is considered as a network of amino acid residues, and inter-residue interactions are described by an atomistic potential function. PDZ domain structures are presented as case studies. The analysis for bovine rhodopsin and three myosin structures are also provided as supplementary case studies. The suggested pathways and the residues constituting the pathways are maximally probable and mostly agree with the previous studies. Overall, it is demonstrated that the communication pathways could be multiple and intrinsically disposed, and the MC path generation approach provides an effective tool for the prediction of key residues that mediate the allosteric communication in an ensemble of pathways and functionally plausible residues. The MCPath server is available at http://safir.prc.boun.edu.tr/clbet_server.

Indexed as

Protein ConformationSoftwareAllosteric RegulationAllosteric SiteInternetMonte Carlo MethodMyosinsPDZ DomainsProtein Tyrosine Phosphatase, Non-Receptor Type 13RhodopsinMyosinsProtein Tyrosine Phosphatase, Non-Receptor Type 13PTPN13 protein, humanRhodopsin

Identifiers

PMID23742907
PMCPMC3692092

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.